It’s a hat trick for Pegasus!
October 16, 2014 |
Pegasus scoops the much-coveted “Consultancy of the Year” prize at the PR Week Awards 2014
Pegasus, the UK’s leading independent health communications consultancy, picked up the prestigious “Consultancy of the Year” award at Tuesday night’s PR Week Awards 2014.
Pegasus was also successful in the “Mid-Sized Consultancy of the Year” category (for agencies with UK turnover between £2m and £10m), and completed its hat trick winning the “Healthcare: Ethical & OTC Consumer” award for its work on Bayer Animal Health’s Slimewatch campaign.
This win marks Pegasus’s evolution from a traditional PR agency to an integrated comms consultancy that offers a multiservice approach to its clients, including social, digital and creative services.
With campaigns that span local, national and international markets and the creation of a network of global independent affiliate agencies across five continents, it’s no surprise that Pegasus represents a raft of well known companies and brands such as GSK, Pfizer, Bayer, Holland & Barrett, Bio-Oil and Danone to name a few. These awards are further confirmation that the consultancy continues to go from strength to strength, creating outstanding integrated campaigns that really bring healthcare into the mainstream. This is the third consultancy award win for the agency this year.
It has seen five years of double-digit growth, with last year’s fee income of £6m helping it climb ten places in this year’s PR Week Top 150 PR Consultancies report to number 38.
Fishburn CEO, Ali Gee said: “Pegasus has everything; it’s clear who they are, what they do and what makes them special.
Their purpose – inspiring health decisions – defines everything they do, and we were particularly impressed by the way they have reached beyond the healthcare sector.” 
Lisa Bradley, managing director at Pegasus, commented: “We’re absolutely delighted to have won, not just one, but three awards at the PR Week Awards this year. I’ve always looked at the winners of the “Consultancy of the Year” award with great admiration and am so proud that we are now that agency.”
ENDS
For more information please contact Maria Boiling or Amy Simmons at Pegasus on 01273 712000 or mboiling@thisispegasus.co.uk / asimmons@thisispegasus.co.uk
Notes to editors
Located in Brighton with a 75-strong team of communications experts, Pegasus specialises in helping the public and private sector communicate healthy messages through integrated communications programmes. Focusing on an overall mission to ‘Inspire Healthy Decisions’ and driven by a health first, sector second approach, Pegasus has a demonstrative track record of creating and implementing campaigns that inspire change.
The Pegasus approach to planning starts by investing time understanding the varied nature of decisions in every area of people’s day to day lives, from the general public through to the healthcare professionals that treat and the policy makers that shape the environment in which they work. The consultancy’s fully integrated approach blends unrivalled health contacts across the international, national, consumer, regional and specialist press, with in-house corporate, creative, social and digital services.
Pegasus’s clients currently include GSK, Pfizer, Boehringer Ingelheim, Bayer, Thornton & Ross, Holland & Barrett, Sanofi, Bio-Oil, Danone, Homedics, Novo Nordisk and Pierre Fabre. For more information please visit www.thisispegasus.co.uk.
This content was provided by Inizio
Company Details
Latest Content from Inizio
Pegasus Moves to Brighton
Top UK Healthcare Communications Consultancy Moves to Brighton
Warehousing of HCV patients reaches new high
A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” patients (holding off treatment) in expectation...
Brand leaders in RA will lose market share, predict rheumatologists
Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.
Removing the Roadblocks to Effective Patient Treatment
How can pharma benefit from improved patient understanding? Welcome to a new column in which Mary Assimakopoulos, Founding Director of pharma market research specialist the Research Partnership reveals findings from...
Driving Earlier Diagnosis: A Case Study in Psoriatic Arthritis
Following a survey of 1000 Psoriatic Arthritis patients, Mary Assimakopoulos shares some of the root causes behind a late diagnosis of this debilitating illness, and the patients’ own feelings towards...
The Difficulties of Living with Depression Don’t End with the Illness Itself
This month Mary Assimakopoulos examines some of the insights gathered while surveying 2,000 patients suffering with this often misunderstood mental illness.
Patient Power: Too Much of a Good Thing?
Mary Assimakopoulos, reveals findings from the company’s Therapy Watch market research data, investigating patient behaviour in Crohn’s Disease and discusses how pharma can benefit from improved patient understanding
Webinar: Mobile Research in Asia and Emerging Markets
Current statistics around mobile technology reveal that many physicians in Asia are now using smartphones, tablets and other mobile devices to assist them in their daily practices. In China alone,73%...
Webinar: Understanding the Patient Journey in Order to Influence Prescribing Decisions
Using real data, this webinar looks at the increasingly popular view that says we need to understand more about the patient and the relationship they have with their physicians in...
Webinar: Focus on China: Conducting Research in the World’s Fastest Growing Pharma Market
This webinar looks to provide market research professionals with an overview of the Chinese healthcare market and provide participants with top tips for conducting relevant and effective market research in...